Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries

被引:189
作者
Fujii, N [1 ]
Oishi, S
Hiramatsu, K
Araki, T
Ueda, S
Tamamura, H
Otaka, A
Kusano, S
Terakubo, S
Nakashima, H
Broach, JA
Trent, JO
Wang, ZX
Peiper, SC
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] St Marianna Univ, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan
[3] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
[4] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
[5] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA
关键词
antagonists; antiviral agents; drug design; high-throughput screening; peptides;
D O I
10.1002/anie.200351024
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
21
引用
收藏
页码:3251 / 3253
页数:3
相关论文
共 18 条
[1]   Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells [J].
Burger, JA ;
Burger, M ;
Kipps, TJ .
BLOOD, 1999, 94 (11) :3658-3667
[2]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[3]  
Fujii N, 2001, Curr Opin Investig Drugs, V2, P1198
[4]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF CYCLIC PENTAPEPTIDE ENDOTHELIN-A RECEPTOR ANTAGONISTS [J].
FUKAMI, T ;
NAGASE, T ;
FUJITA, K ;
HAYAMA, T ;
NIIYAMA, K ;
MASE, T ;
NAKAJIMA, S ;
FUKURODA, T ;
SAEKI, T ;
NISHIKIBE, M ;
IHARA, M ;
YANO, M ;
ISHIKAWA, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) :4309-4324
[5]   Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin alpha(v)beta(3) antagonists [J].
Haubner, R ;
Gratias, R ;
Diefenbach, B ;
Goodman, SL ;
Jonczyk, A ;
Kessler, H .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (32) :7461-7472
[6]  
Haubner R., 1997, ANGEW CHEM, V109, P1440
[7]  
Haubner R., 1997, ANGEW CHEM INT EDIT, V36, P1374
[8]   Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads [J].
Hruby, VJ ;
Balse, PM .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (09) :945-970
[9]   Novel peptidomimetics of the antifungal cyclic peptide rhodopeptin: Synthesis of mimetics and their antifungal activity [J].
Kawato, HC ;
Nakayama, K ;
Inagaki, H ;
Ohta, T .
ORGANIC LETTERS, 2001, 3 (22) :3451-3454
[10]  
KESSLER H, 1985, PEPTIDES 1985, P83